Signaling Pathways - Cell Experiments - Rheumatoid Arthritis - Bladder Carcinoma - Thyroid Cancer
清除全部
- B4664 T-522410 CitationTarget: AP-1|MMPSummary: C-Fos/AP-1抑制剂
- B1112 MerimepodibTarget: IMPDHSummary: IMPDH(肌苷单磷酸脱氢酶)的新型非竞争性抑制剂
- B2284 Fostamatinib (R788)中文名: 福坦替尼Target: SykSummary: 脾酪氨酸激酶(Syk)抑制剂
- A8686 VX-745Target: p38Summary: P38α抑制剂
- A8332 R788 disodium中文名: 福他替尼二钠盐Target: SykSummary: Syk的ATP竞争性抑制剂
- A1947 MEK162 (ARRY-162, ARRY-438162)中文名: 贝美替尼Target: MEKSummary: MEK1/2抑制剂
- A5176 AS-605240Target: PI3KSummary: PI 3-Kγ选择性抑制剂
- A3632 Motesanib中文名: 莫特塞尼Target: VEGFRSummary: Flk-1/Flt-4/PDGFR-/c-Kit抑制剂
- A3573 LY2801653Target: METSummary: MET抑制剂
- A1926 CA 0742 CitationTarget: CathepsinsSummary: Cathepsin B抑制剂